Hims & Hers Health Inc.(HIMS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HIMS Hims & Hers Health Inc.

盘后交易 04-29 16:13:00 EDT

26.33

-1.58

-5.66%

盘后26.37

+0.04+0.14%

16:12 EDT

最高27.69	最低26.04	成交量1,966万
今开27.62	昨收27.91	日振幅5.90%
总市值59.94亿	流通市值52.00亿	总股本2.28亿
成交额5.21亿	换手率9.95%	流通股本1.98亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"HIMS","market":"US","secType":"STK","nameCN":"Hims & Hers Health Inc.","latestPrice":26.33,"timestamp":1777492800000,"preClose":27.91,"halted":0,"volume":19660730,"hourTrading":{"tag":"盘后","latestPrice":26.3679,"preClose":26.33,"latestTime":"16:12 EDT","volume":490354,"amount":12912705.18599,"timestamp":1777493565131,"change":0.0379,"changeRate":0.001439,"amplitude":0.006457},"delay":0,"changeRate":-0.056610533858832024,"floatShares":197512273,"shares":227648514,"eps":0.512286,"marketStatus":"盘后交易","change":-1.58,"latestTime":"04-29 16:13:00 EDT","open":27.62,"high":27.6858,"low":26.04,"amount":521286207.39985996,"amplitude":0.058968,"askPrice":26.45,"askSize":262,"bidPrice":26.15,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.512286,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1777507200000},"marketStatusCode":4,"adr":0,"exchange":"NYSE","adjPreClose":27.91,"preHourTrading":{"tag":"盘前","latestPrice":27.61,"preClose":27.91,"latestTime":"09:29 EDT","volume":124702,"amount":3473881.475728,"timestamp":1777469399999,"change":-0.3,"changeRate":-0.010749,"amplitude":0.020064},"postHourTrading":{"tag":"盘后","latestPrice":26.3679,"preClose":26.33,"latestTime":"16:12 EDT","volume":490354,"amount":12912705.18599,"timestamp":1777493565131,"change":0.0379,"changeRate":0.001439,"amplitude":0.006457},"volumeRatio":0.593081,"optionData":{"bulkOrders":[{"symbol":"HIMS","call":true,"expireDate":1799989200000,"strike":"50.0","timestamp":1777476219081,"price":3.75,"volume":4919,"amount":1844625,"type":"+"},{"symbol":"HIMS","call":true,"expireDate":1778212800000,"strike":"28.0","timestamp":1777470904488,"price":1.14,"volume":2000,"amount":228000,"type":"+"}]},"impliedVol":1.0947,"impliedVolPercentile":0.741},"requestUrl":"/m/hq/s/HIMS","defaultTab":"news","newsList":[{"id":"2630459397","title":"OKX 将上线 USAR、COST、LLY、HIMS、BMNR 股票永续合约","url":"https://stock-news.laohu8.com/highlight/detail?id=2630459397","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630459397?lang=zh_cn&edition=full","pubTime":"2026-04-27 21:01","pubTimestamp":1777294911,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，OKX 将于 2026 年 4 月 27 日 22:00 正式上线 USAR/USDT 股票永续合约，随后 COST/USDT 合约于 22:15 开盘，LLY/USDT 合约于 22:30 开盘，HIMS/USDT 合约于 22:45 开盘，BMNR/USDT 合约于 23:00 开盘。所有合约均以 USDT 结算，交易时间为 7×24 小时。 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2261129","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","LLII","HK0000819398.USD","LU0106261372.USD","LU1551013342.USD","LU2756315318.SGD","SG9999018857.SGD","COST","LU0203201768.USD","LU2111349929.HKD","HIYY","LU0225283273.USD","LU1023059063.AUD","LU1720051108.HKD","LU0708995401.HKD","LU2750360997.AUD","LU2746668461.USD","BK4534","IE00BK4W5M84.HKD","LU1868836757.USD","LU2746668974.SGD","LU0353189763.USD","LU1066051498.USD","LU1496350171.SGD","LU2357305700.SGD","LU2028103732.USD","LU2237443978.SGD","LU2468319806.SGD","LU2471134879.HKD","LU2237443549.SGD","ELIS","LU0354030511.USD","LU0820562030.AUD","LU2237443382.USD","LU1571399168.USD","LU2324357040.USD","BK4168","BK4504","LU1291159041.SGD","LU2750360641.GBP","LU2112291526.USD","SGXZ51526630.SGD","SG9999014880.SGD","BK4588","LU0323591593.USD","LU2210150020.SGD","LU0882574055.USD","LU2211815571.USD","LU1145028129.USD","IE0002141913.USD","SG9999013999.USD","LU0238689110.USD","LU2237443895.HKD","SG9999015952.SGD","BK4023","LU0097036916.USD","LU2095319765.USD","IE00BK4W5L77.USD","IE00BWXC8680.SGD","LU1548497426.USD","LU0158827781.USD","IE00BFSS7M15.SGD","BK4550","LU1323610961.USD","LU2491049909.HKD","LU0094547139.USD","LU2265009873.SGD","LU2602419157.SGD","BK4147","LU0122379950.USD","YBMN","LU0672654240.SGD","LU1116320901.HKD","USAX","BK4516","LU2381873111.SGD","LU1127390331.HKD","BK4599","LU0640476718.USD","SGXZ31699556.SGD","ELIL","LU0234570918.USD","SGXZ99366536.SGD","HIMZ","LU0432979614.USD","LU0354030438.USD","LU1551013425.SGD","LU1712237335.SGD","LU0823434583.USD","LU1280957306.USD","LU0471298777.SGD","LU0823416689.USD","GB00BDT5M118.USD","IE00B1BXHZ80.USD","IE00BJLML261.HKD","LU0882574139.USD","LU0320765059.SGD","LU0787776722.HKD","SG9999001176.SGD","BK4581","BK4155","HIMS","LU1366192091.USD","LU2106854487.HKD","LU2237443622.USD","LU2491050071.SGD","BK4596","LU2756315664.SGD","IE00BKDWB100.SGD","LU0198837287.USD","LU2089283258.USD","LU0133085943.USD","LU0265550359.USD","LU2125154935.USD","BK4007","LU0786609619.USD","LU0158827948.USD","IE00BZ1G4Q59.USD","LU1066051811.HKD","IE00BN29S564.USD","LU2237443465.HKD","LU0203202063.USD","SG9999014906.USD","IE00B775H168.HKD","LU2360032135.SGD","LU2456880835.USD","LU1804176565.USD","LU1988902786.USD","LU2168564149.EUR","LU0109391861.USD","LU2361044865.SGD","SG9999018865.SGD","BK4585","LLYZ","IE0008368304.USD","LU2361044949.HKD","LU2213496289.HKD","LU2471134796.USD","LU0943347566.SGD","LU1974910355.USD","SG9999015978.USD","LU0079474960.USD","LU0058720904.USD","LU1069344957.HKD","LU0265550946.USD","LU0256863811.USD","LU1064131342.USD","IE0004445239.USD","SG9999001176.USD","LU0456855351.SGD","LU2023250330.USD","LU1093756325.SGD","LU0689472784.USD","LU0683600562.USD","LU1623119135.USD","LU1868836591.USD","IE00BKPKM429.USD","IE0001KFT4U8.USD","LU0471298694.HKD","LU1232071149.USD","LU2264538146.SGD","HMYY","LU2108987350.USD","LU1035775433.USD","LU0889565916.HKD","BMNZ","LU0234572021.USD","LU2471134523.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU2237438978.USD","LU0096364046.USD","LU0210536198.USD","IE00BKVL7J92.USD","LU2462157665.USD","LU1496350502.SGD","LU2210149790.SGD","LU2417539215.USD","LU0353189680.USD","LU0061475181.USD","LU2023251221.USD","LU2089284900.SGD","LU2089984988.USD","LU0289739699.SGD","LU0466842654.USD","BMNU","IE0009355771.USD","LU2360106947.USD","SG9999014914.USD","LU2063271972.USD","USGG","LU2896262040.SGD","SG9999017495.SGD","LLY","LU1917777945.USD","LU0385154629.USD","SG9999015945.SGD","SG9999014898.SGD","IE00B4JS1V06.HKD","LU1720051017.SGD","LU2491050154.USD","LU2552382215.SGD","LU0417517546.SGD","IE00BFSS8Q28.SGD","LU1116320737.USD","LU2361045086.USD","LU2087625088.SGD","COTG","LU2125154778.USD","SGXZ81514606.USD","IE00B5TLWC47.USD","LU2168563687.JPY","LU2097829019.USD","LU1093756168.USD","LU0964807845.USD","HIMY","LU1983299246.USD","LU1868837136.USD","LU1989771016.USD","LU2271345857.HKD","LU0256863902.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE0004445015.USD","LLYX","LU2168564495.EUR","LU2552382058.USD","LU0109394709.USD","LU1057294990.SGD","IE00BJJMRX11.SGD","IE00B2B36J28.USD","LU2461242641.AUD","LU1629891620.HKD","LU0266013472.USD","BK4533","IE00BJJMRY28.SGD","LU2168564065.EUR","LU2552382132.HKD","LU1814569148.SGD","LU1868836914.USD","LU2471134952.CNY","LU0114720955.EUR","LU1066051225.USD","LU0320765992.SGD","LU0316494557.USD","LU0820561818.USD","LU0823434740.USD","LU1267930730.SGD","LU0006306889.USD","IE0005OL40V9.USD","BMNG","LU2023250504.SGD","LU0820561909.HKD","LU1066053197.SGD","IE00B1XK9C88.USD","SG9999015986.USD","COSW","LU1868837300.USD","LU2236285917.USD","IE00B7KXQ091.USD","SGXZ57979304.SGD","LU1061106388.HKD","LU2168564222.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161869726","title":"异动解读 | Hims & Hers Health盘中大涨6.22%，获摩根大通“增持”评级并上架GLP-1药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1161869726","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161869726?lang=zh_cn&edition=full","pubTime":"2026-04-24 21:36","pubTimestamp":1777037785,"startTime":"0","endTime":"0","summary":"远程医疗服务提供商Hims & Hers Health Inc.  今日盘中股价大幅上涨6.22%，引起了市场的广泛关注。首先，摩根大通首次覆盖该公司并给予“增持”评级，目标价定为35美元，显著高于市场此前的一致预期。分析师指出，更稳定的GLP-1业务线、潜在的肽类药物政策利好、以及下半年营收加速增长的可能性，共同构成了公司未来发展的积极催化剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113178589","title":"异动解读 | 获摩根大通初评“增持”，Hims & Hers Health盘前大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113178589","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113178589?lang=zh_cn&edition=full","pubTime":"2026-04-24 20:18","pubTimestamp":1777033128,"startTime":"0","endTime":"0","summary":"远程医疗服务提供商Hims & Hers Health Inc.  今日盘前股价大涨5.04%，引起了市场关注。消息面上，此次股价上涨主要得益于摩根大通首次覆盖该公司并给予“增持”评级，目标价定为35美元。值得注意的是，摩根大通维持HIMS目标价35美元，较上一收盘价有24%的上行空间。在覆盖该股的17家券商中，有12家给予“持有”评级，5家给予“买入”评级，目标价中位数为24.5美元。该券商同时指出，HIMS仍是标普400指数中做空比例最高的个股之一。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1b5e0887bced2e980404b6424415259e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196187940","title":"Hims & Hers Health获摩根大通初评“增持” 盘前股价应声上涨2.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1196187940","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196187940?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:08","pubTimestamp":1777018125,"startTime":"0","endTime":"0","summary":"在摩根大通首次覆盖并给予“增持”评级后，远程医疗服务提供商Hims & Hers Health Inc.股价在盘前交易中应声走高，涨幅达2.2%。\n此次积极的机构评级为该公司股价提供了即时动力，反映出市场对其业务前景的乐观情绪。分析师通常将“增持”评级授予他们预期表现将优于市场平均或行业同行的公司。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","HIYY","BK4196","HIMS","HMYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158230324","title":"异动解读 | 获利回吐压力显现，Hims & Hers Health盘中大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=1158230324","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158230324?lang=zh_cn&edition=full","pubTime":"2026-04-24 02:29","pubTimestamp":1776968959,"startTime":"0","endTime":"0","summary":"远程医疗平台Hims & Hers Health Inc.今日盘中股价出现大跌，跌幅达5.03%。消息面上，尽管公司近期利好频传，包括FDA放松多肽类药物监管、与诺和诺德达成合作、以及其HIMS平台全面上架多款FDA认证的GLP-1药物，为股价提供了强劲的上行动力，但市场在持续上涨后正面临短线获利了结的压力。此外，公司近日披露的持股变动声明及拟议出售证券相关公告，显示内部股东持仓存在调整动向，也引发了市场的关注与谨慎情绪。综合来看，在前期一系列利好消息推动股价大幅走强后，获利盘的回吐以及内部持股可能的变化，共同导致了今日盘中的显著回调。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a5fde094a4dd82d0538563a7d0b35f81","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140294257","title":"Hims & Hers获FDA批准GLP-1疗法：合作医疗机构可为客户开具处方并由独立药房配药","url":"https://stock-news.laohu8.com/highlight/detail?id=1140294257","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140294257?lang=zh_cn&edition=full","pubTime":"2026-04-23 20:45","pubTimestamp":1776948351,"startTime":"0","endTime":"0","summary":"远程医疗平台Hims & Hers Health Inc.宣布，其合作医疗提供者现可为客户开具经美国食品药品监督管理局（FDA）批准的GLP-1类治疗方案。相关药物将由独立药房负责配送供应，确保患者获得持续性的专业医疗支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1b5e0887bced2e980404b6424415259e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","HIMY","HIMS","HIMZ","BK4196","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113714146","title":"HIMS平台全面上架多款FDA认证的GLP-1药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1113714146","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113714146?lang=zh_cn&edition=full","pubTime":"2026-04-23 20:43","pubTimestamp":1776948205,"startTime":"0","endTime":"0","summary":"4月23日，Hims & Hers Health盘前一度涨超9%，HIMS平台全面上架多款FDA认证的GLP-1药物，涵盖礼来Zepbound针剂、注射笔及Foundayo口服药。","market":"us","thumbnail":"https://static.tigerbbs.com/bc7ad619aa7e42a7db4703997b65806b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/bc7ad619aa7e42a7db4703997b65806b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1b5e0887bced2e980404b6424415259e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"HIMS平台全面上架多款FDA认证的GLP-1药物","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HIYY","HMYY","HIMZ","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170136747","title":"异动解读 | FDA多肽药物放松监管及与诺和诺德合作，Hims & Hers Health盘前大涨7.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=1170136747","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170136747?lang=zh_cn&edition=full","pubTime":"2026-04-23 20:40","pubTimestamp":1776948018,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. (HIMS) 今日盘前股价大涨7.79%，引起了市场的广泛关注。消息面上，美国食品药品监督管理局（FDA）此前宣布放松对多肽类药物的监管政策，叠加公司与诺和诺德达成合作关系，持续推动股价走强。此前该股曾在一周内累计大涨逾50%，随后经历回调，本次盘前反弹显示市场围绕FDA多肽政策利好与短线获利回吐之间持续博弈。此外，公司近日披露的持股变动声明及拟议出售证券相关公告，内部人士动向亦受到市场关注。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1b5e0887bced2e980404b6424415259e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171263605","title":"异动解读 | 与诺和诺德合作及FDA利好消息推动，Hims & Hers Health夜盘大涨5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=1171263605","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171263605?lang=zh_cn&edition=full","pubTime":"2026-04-22 08:02","pubTimestamp":1776816175,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. (HIMS) 今日夜盘股价大涨5.61%，引起了市场的广泛关注。消息面上，推动股价上涨的主要催化剂包括：丹麦制药巨头诺和诺德宣布与Hims达成合作，将在其平台销售减肥药物；以及美国食品药品监督管理局(FDA)宣布计划将12种肽类药物从二级限制清单中移除，并拟于7月召开专家会议讨论复方药房生产肽类药物的可行性。这两大利好消息显著提升了市场对该公司未来增长潜力的预期。尽管该股在日间交易时段曾出现回调，但夜盘交易中市场情绪再度转向积极，反映了投资者对上述长期利好消息的持续认可。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150435965","title":"期权大单｜获排雷大单催化！Ondas看涨期权占比攀升至80%；与英伟达深化合作！黑莓股价飙升，期权成交量激增","url":"https://stock-news.laohu8.com/highlight/detail?id=1150435965","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150435965?lang=zh_cn&edition=full","pubTime":"2026-04-21 10:10","pubTimestamp":1776737410,"startTime":"0","endTime":"0","summary":"期权方面，Ondas当日成交近50万张，较90日均量放大逾2倍，看涨期权占比攀升至近80%，其中于4月24日到期的11美元行使价的看涨期权成交居前，成交近4万张。这一组合旨在开发安全可靠的AI解决方案，以满足严格的安全标准，应对日益增长的边缘AI技术需求。根据披露的细节，此次洽谈的核心围绕两款旨在显著提升 AI 模型运行效率的新型芯片。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"324431b18d184842b2237adf08e51534","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONDG","HIMZ","HMYY","HIMS","MRVL","ONDS","HIYY","ONDL","ONDU","MVLL","HIMY","BB","MRVU"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1141153170","title":"异动解读 | FDA肽类药物松绑预期提振，Hims & Hers Health盘中大涨6.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1141153170","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141153170?lang=zh_cn&edition=full","pubTime":"2026-04-20 21:57","pubTimestamp":1776693429,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. (HIMS) 今日盘中大涨6.23%，引起了市场的广泛关注。消息面上，美国FDA近日正式宣布将于7月召开咨询委员会会议，讨论是否允许持牌配制药房重新生产部分此前被限制的肽类药物产品，涵盖7种多肽，涉及减重、伤口愈合及改善失眠等领域。这一监管松绑预期对Hims & Hers意义重大，该公司作为平价减肥药供应商及远程医疗平台，肽类药物限制的放宽将显著扩大其在减重及健康业务领域的可及市场，市场情绪持续受到提振。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7bc8ed1fa728240996d692d61737544f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137583584","title":"Hims & Hers Health续涨近10%！美国FDA正计划对肽类药物监管进行松绑","url":"https://stock-news.laohu8.com/highlight/detail?id=1137583584","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137583584?lang=zh_cn&edition=full","pubTime":"2026-04-17 21:52","pubTimestamp":1776433933,"startTime":"0","endTime":"0","summary":"4月17日，Hims & Hers Health续涨近10%，该股本周累涨逾50%！美国食品药品监督管理局(FDA)正计划对肽类药物监管进行松绑。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b2ce105ab495aa94fa9ad67cd213a291","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers Health续涨近10%！美国FDA正计划对肽类药物监管进行松绑","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187603951","title":"异动解读 | Hims & Hers Health盘中大涨9.74%，FDA肽类药物松绑预期提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1187603951","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187603951?lang=zh_cn&edition=full","pubTime":"2026-04-17 21:44","pubTimestamp":1776433475,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc.  今日盘中股价大幅上涨9.74%，引起了市场的广泛关注。消息面上，美国食品药品监督管理局正计划对肽类药物监管进行松绑。根据相关文件，FDA将于7月召集专家小组，讨论部分药店生产某些肽类物质的可行性，并敲定松绑细节。据悉，FDA正在考虑将12种肽类药物从二级限制清单中移除，另有7种肽类药物将于7月接受审查。Hims & Hers Health作为一家平价减肥药及健康服务供应商，其减重与健康业务有望直接受益于此次监管放松。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b2ce105ab495aa94fa9ad67cd213a291","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171008736","title":"异动解读 | FDA拟放宽多肽限制叠加与诺和诺德合作利好，Hims & Hers Health盘中大涨11.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1171008736","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171008736?lang=zh_cn&edition=full","pubTime":"2026-04-17 02:25","pubTimestamp":1776363907,"startTime":"0","endTime":"0","summary":"互联网医疗公司Hims & Hers Health Inc.今日盘中大幅上涨11.14%，引起了市场的广泛关注。这一监管动向被视为对作为平价减肥药供应商的Hims & Hers Health的积极信号，有望使其相关产品走出“灰色市场”，进入更规范的销售渠道。其次，公司宣布与丹麦制药巨头诺和诺德达成合作，后者将通过Hims平台销售其减肥药物，此举意味着Hims正式切入市场需求旺盛的GLP-1减肥药赛道。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"043c775ad1acc6f08ee5e7589ea0df12","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188459504","title":"异动解读 | 与诺和诺德达成合作叠加FDA利好，Hims & Hers Health盘前大涨10.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188459504","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188459504?lang=zh_cn&edition=full","pubTime":"2026-04-16 16:06","pubTimestamp":1776326786,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc.今日盘前股价大幅上涨10.66%，引起了市场的广泛关注。首先，美国食品药品监督管理局正式宣布将于7月召开专家会议，以敲定肽类药物全面松绑的细节，这一监管动向被视为对作为平价减肥药供应商的Hims & Hers Health的积极信号。此外，公司宣布与丹麦制药巨头诺和诺德达成合作，后者将通过Hims平台销售其减肥药物。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"043c775ad1acc6f08ee5e7589ea0df12","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128070922","title":"FDA正式官宣7月召开专家会议，敲定肽类药物全面松绑细节","url":"https://stock-news.laohu8.com/highlight/detail?id=1128070922","media":"老虎资讯综合","labels":["policyRegulatory","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128070922?lang=zh_cn&edition=full","pubTime":"2026-04-16 08:26","pubTimestamp":1776299160,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局(FDA)周三提交的文件显示，该机构将于7月召集专家小组，讨论部分药店是否可以生产某些肽类物质。这些物质未经证实，但在健康领域的意见领袖和运动员中越来越受欢迎。受此消息影响，平价减肥药供应商Hims & Hers Health股价大涨。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"324431b18d184842b2237adf08e51534","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"FDA正式官宣7月召开专家会议，敲定肽类药物全面松绑细节","news_tag":"policyRegulatory,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118801610","title":"美股夜盘 | HIMS续涨10%，Robinhood续涨3%；量子计算、核电股续涨，SMR涨近5%，IONQ涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1118801610","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118801610?lang=zh_cn&edition=full","pubTime":"2026-04-16 08:16","pubTimestamp":1776298576,"startTime":"0","endTime":"0","summary":"4月16日，美股夜盘时段，量子计算概念股续涨，$D-Wave Quantum(QBTS)$、$Arqit Quantum(ARQQW)$、IONQ涨超3%，$Quantum Computing(QUBT)$涨近3%，$Rigetti Computing(RGTI)$涨近2%。核电股$NuScale Power(SMR)$续涨近5%，Oklo涨超3%。平价减肥药供应商$Hims & Hers Health(HIMS)$续涨超10%，FDA正式官宣7月召开专家会议，敲定肽类药物全面松绑细节。$Robinhood(HOOD)$续涨超3%，美国SEC批准取消投资者日内交易限制的计划。","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f2325dda5620875f8564357c4c565fe1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOOZ","BK4608","HOOX","QPUX","HOOG","HOOI","HIMS","HMYY","BK4127","NLR","HODU","BK4588","HOOY","URAN","IONQ","BK4606","SMR","BK4591","BK4196","IONL","SMUP","URNM","NUKZ","HIMY","BK4585","LU1861559042.SGD","HOOW","SMZ","IONZ","BK4539","HOII","HIMZ","BK4170","HIYY","HOOD","BK4182","IOYY","DRLL","LU1861558580.USD","HOYY","BK4547","BK4602","BK4023","ROBN","IONX","SMU","IONQ.WS","QTUM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144044986","title":"异动解读 | AI医疗概念持续升温，Hims & Hers Health夜盘大涨10.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=1144044986","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144044986?lang=zh_cn&edition=full","pubTime":"2026-04-16 08:04","pubTimestamp":1776297883,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc.（股票代码：HIMS）今日夜盘股价大幅上涨10.33%，引起了市场的广泛关注。消息面上，AI医疗应用概念近期持续升温，成为市场关注的焦点。此前，AI驱动的远程医疗平台Medvi以极少人力实现高额营收的成功案例，以及OpenAI首席执行官萨姆·奥尔特曼公开讨论的“十亿美元一人公司”话题，均极大地激发了市场对人工智能在医疗保健领域应用前景的期待。Hims & Hers Health作为在线健康平台赛道的代表性上市公司，被市场普遍视为这轮AI医疗应用浪潮的核心受益标的之一。资金的持续涌入是推动其股价走强的主要动力。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140144585","title":"异动解读 | AI医疗概念持续升温，Hims & Hers Health盘中大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=1140144585","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140144585?lang=zh_cn&edition=full","pubTime":"2026-04-16 02:40","pubTimestamp":1776278450,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc.今日盘中股价大幅上涨5.41%，引起了市场的广泛关注。消息面上，AI医疗应用概念近期持续升温，成为市场关注的焦点。Hims & Hers Health作为在线健康平台赛道的代表性上市公司，拥有超过2400名员工和年营收约24亿美元的规模，被市场普遍视为这轮AI医疗应用浪潮的核心受益标的之一。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155256862","title":"Hims & Hers Health公司回应：已着手审查受影响的客服工单，以确定所涉信息内容及关联对象","url":"https://stock-news.laohu8.com/highlight/detail?id=1155256862","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155256862?lang=zh_cn&edition=full","pubTime":"2026-04-03 05:40","pubTimestamp":1775166038,"startTime":"0","endTime":"0","summary":"作为应对措施，Hims & Hers Health Inc. 已启动对相关服务工单的全面审查。此项审查旨在明确工单中所包含的具体信息内容，并进一步厘清这些信息所关联的个体或实体。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","BK4196","HIMZ","HMYY","HIMS","HIMY"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0622},{"period":"1month","weight":0.4401},{"period":"3month","weight":-0.0265},{"period":"6month","weight":-0.3665},{"period":"1year","weight":-0.02},{"period":"ytd","weight":-0.1404}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.1224},{"period":"3month","weight":0.0234},{"period":"6month","weight":0.0469},{"period":"1year","weight":0.292},{"period":"ytd","weight":0.0437}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Hims & Hers Health Inc是一家多专业远程医疗平台，将消费者与持牌医疗保健专业人员联系起来，使他们能够获得与心理健康、性健康、皮肤病学、头发护理等相关的多种疾病的高质量医疗服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.098962},{"month":2,"riseRate":0.571429,"avgChangeRate":0.066017},{"month":3,"riseRate":0.428571,"avgChangeRate":0.011001},{"month":4,"riseRate":0.428571,"avgChangeRate":0.023639},{"month":5,"riseRate":0.5,"avgChangeRate":0.191652},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.021115},{"month":7,"riseRate":0.666667,"avgChangeRate":0.073238},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.14623},{"month":9,"riseRate":0.5,"avgChangeRate":0.080437},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.073266},{"month":11,"riseRate":0.714286,"avgChangeRate":0.187933},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.001486}],"exchange":"NYSE","name":"Hims & Hers Health Inc.","nameEN":"Hims & Hers Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Hims & Hers Health Inc.(HIMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Hims & Hers Health Inc.(HIMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Hims & Hers Health Inc.,HIMS,Hims & Hers Health Inc.股票,Hims & Hers Health Inc.股票老虎,Hims & Hers Health Inc.股票老虎国际,Hims & Hers Health Inc.行情,Hims & Hers Health Inc.股票行情,Hims & Hers Health Inc.股价,Hims & Hers Health Inc.股市,Hims & Hers Health Inc.股票价格,Hims & Hers Health Inc.股票交易,Hims & Hers Health Inc.股票购买,Hims & Hers Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Hims & Hers Health Inc.(HIMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Hims & Hers Health Inc.(HIMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}